Immunosuppressive therapy improves pancytopenia in severe aplastic anemia.However, its effects are not long-lasting as evidenced by a modest 2-year EFS rate of just 46%, prompting the need for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback